| Pharmaceutical Formulations | Generic and branded generics formulations across 36 therapeutic classes including injectables, oncology, biosimilars. | Strong regulatory approvals, integrated manufacturing, extensive product registrations, and supply chain footprint in emerging markets. | B2B and B2C including distributors, hospitals, pharmacies in emerging and regulated markets. | Specialty injectables, oncology products, biosimilars, and niche formulations in regulated markets. | 1937 | 100 | Sales of finished pharmaceuticals through direct sales, distribution and tender contracts. | Tiered sales pricing, direct contracts, and tender-based agreements. | Expansion in Latin America, US FDA approvals, pipeline launches, oncology and API integration. | Caplin Steriles, Caplin One Labs |
